Total Payments
$3.1M
2024 Payments
$675,875
Companies
17
Transactions
3,443
Payment Breakdown by Category
Other$2.6M (85.0%)
Travel$340,240 (11.1%)
Food & Beverage$61,861 (2.0%)
Consulting$58,799 (1.9%)
Education$213.97 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2.6M | 1,163 | 85.0% |
| Travel and Lodging | $340,240 | 1,060 | 11.1% |
| Food and Beverage | $61,861 | 1,197 | 2.0% |
| Consulting Fee | $58,799 | 16 | 1.9% |
| Education | $213.97 | 7 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $750,277 | 922 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $715,878 | 777 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $652,488 | 671 | $0 (2024) |
| ITI, Inc. | $369,326 | 366 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $188,052 | 172 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $149,737 | 228 | $0 (2022) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $111,883 | 110 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $94,848 | 78 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $39,947 | 72 | $0 (2024) |
| Lundbeck LLC | $565.16 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $675,875 | 595 | Alkermes, Inc. ($140,831) |
| 2023 | $503,864 | 455 | Neurocrine Biosciences, Inc. ($117,838) |
| 2022 | $448,044 | 483 | ITI, Inc. ($158,335) |
| 2021 | $336,911 | 377 | Janssen Pharmaceuticals, Inc ($113,700) |
| 2020 | $174,656 | 265 | ITI, Inc. ($64,870) |
| 2019 | $249,401 | 382 | Alkermes, Inc. ($106,841) |
| 2018 | $306,314 | 404 | Neurocrine Biosciences, Inc. ($113,489) |
| 2017 | $378,324 | 482 | Janssen Pharmaceuticals, Inc ($113,372) |
All Payment Transactions
3,443 individual payment records from CMS Open Payments — Page 1 of 138
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: PSYCHIATRY | ||||||
| 12/20/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $16.86 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $127.43 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,608.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,007.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/18/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: CNS | ||||||
| 12/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,160.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $122.48 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Travel and Lodging | Cash or cash equivalent | $1,866.45 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $131.53 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $28.15 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/13/2024 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $32.58 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $29.81 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,320.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Travel and Lodging | In-kind items and services | $688.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $31.25 | General |
| Category: CNS | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Travel and Lodging | Cash or cash equivalent | $1,627.91 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Travel and Lodging | Cash or cash equivalent | $243.83 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $137.05 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,171.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,209.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,044.00 | General |
| Category: Psychiatry/Psychology | ||||||
About Dr. Mark Reynolds, MD
Dr. Mark Reynolds, MD is a Psychiatry healthcare provider based in Durham, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023052503.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Reynolds, MD has received a total of $3.1M in payments from pharmaceutical and medical device companies, with $675,875 received in 2024. These payments were reported across 3,443 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($2.6M).
Ad
Practice Information
- Specialty Psychiatry
- Location Durham, NC
- Active Since 06/15/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1023052503
Products in Payments
- INGREZZA (Drug) $715,878
- INVEGA SUSTENNA (Drug) $498,771
- ARISTADA (Drug) $487,155
- CAPLYTA (Drug) $481,209
- UZEDY (Drug) $187,793
- Aristada 441 mg (Drug) $182,857
- INVEGA TRINZA (Drug) $151,700
- LATUDA (Drug) $149,485
- LYBALVI (Drug) $80,186
- COBENFY (Drug) $70,589
- ABILIFY MAINTENA (Drug) $30,508
- REXULTI (Drug) $9,852
- INVEGA (Drug) $1,515
- SPRAVATO (Drug) $226.75
- ABILIFY ASIMTUFII (Drug) $153.14
- AUSTEDO (Drug) $141.03
- VRAYLAR (Drug) $122.89
- PERSERIS (Drug) $108.45
- LONHALA MAGNAIR (Drug) $84.15
- Vivitrol 380 mg (Drug) $79.03
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Durham
Dr. Steven Szabo, M.d., Ph.d, M.D., PH.D
Psychiatry — Payments: $533,466
Psychiatry $533,466
Andrew Krystal, M.d, M.D
Psychiatry — Payments: $269,097
Psychiatry $269,097
Mustafa Husain, Md, MD
Psychiatry — Payments: $72,752
Psychiatry $72,752
Dr. Caleb Whitenack, M.d, M.D
Psychiatry — Payments: $60,812
Psychiatry $60,812
Julie Adams, Md, MD
Psychiatry — Payments: $59,600
Psychiatry $59,600
Paolo Mannelli, M.d, M.D
Psychiatry — Payments: $49,253
Psychiatry $49,253